GLT1D1 and neoplasm: These data together suggest that GLT1D1 could promote PD‐L1 glycosylation and enhance its stabilization in vivo, and thus promote tumor growth by suppressing cytotoxic CD8+ T cells in the tumor microenvironment, as illustrated schematically in Fig. 7.